These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5964385)

  • 21. Induced candidosis in mice with artificially established oral flora.
    van Wyk CW; Basson NJ; Theunissen F
    J Dent Assoc S Afr; 1996 Jul; 51(7):427-32. PubMed ID: 9462024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological changes in the thymus in the course of experimental chronic Candida albicans infection in mice.
    Mankowski ZT
    Mycopathol Mycol Appl; 1968 Dec; 36(3):233-46. PubMed ID: 5704124
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pulmonary candidiasis].
    Yamamoto K
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):335-8. PubMed ID: 10201217
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of thyroliberin on the course of experimental candidosis in mice.
    Błaszkowska J; Pawlikowski M; Komorowski J; Kurnatowski P
    Mycoses; 2004 Apr; 47(3-4):115-20. PubMed ID: 15078427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of host defenses by cyclosporine. Influence of the route of administration on the course of infection.
    Findon G; Miller TE
    Transplantation; 1988 Apr; 45(4):815-7. PubMed ID: 3358279
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bronchitis micoticans candidiasis].
    Panajotović H
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():509-16. PubMed ID: 4614294
    [No Abstract]   [Full Text] [Related]  

  • 27. Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice.
    Sundstrom P; Balish E; Allen CM
    J Infect Dis; 2002 Feb; 185(4):521-30. PubMed ID: 11865405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Action of lysozyme in experimental Candida albicans infections].
    Tarsi R; Orpianesi C; La Rosa F; Evangelista AM
    Farmaco Prat; 1978 Jun; 33(6):276-88. PubMed ID: 744228
    [No Abstract]   [Full Text] [Related]  

  • 29. Utility of the oestrogen-dependent vaginal candidosis murine model in evaluating the efficacy of various therapies against vaginal Candida albicans infection.
    Hamad M; Muta'eb E; Abu-Shaqra Q; Fraij A; Abu-Elteen K; Yasin SR
    Mycoses; 2006 Mar; 49(2):104-8. PubMed ID: 16466442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A second Candida albicans resistance gene (Carg2) regulates tissue damage, but not fungal clearance, in sub-lethal murine systemic infection.
    Ashman RB; Fulurija A; Papadimitriou JM
    Microb Pathog; 1998 Dec; 25(6):349-52. PubMed ID: 9895274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Listeria monocytogenes lipids on the immunity of mice against Candida albicans, Cryptococcus neoformans and Trichomonas vaginalis.
    Jakoniuk P; Jabłońska-Strynkowska W; Musiatowicz B; Borowski J
    Arch Immunol Ther Exp (Warsz); 1980; 28(3):377-87. PubMed ID: 6778451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial organ localisation of blood-borne Candida albicans in a rat model of disseminated candidosis.
    Katz S; Grosfeld JL; Folkening WJ; Rosenthal RS; Merkel GJ
    J Med Microbiol; 1992 Oct; 37(4):291-5. PubMed ID: 1404330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice.
    MacCallum DM; Odds FC
    Mycoses; 2005 May; 48(3):151-61. PubMed ID: 15842329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal models in the analysis of Candida host-pathogen interactions.
    de Repentigny L
    Curr Opin Microbiol; 2004 Aug; 7(4):324-9. PubMed ID: 15288620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
    Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals.
    Segal E; Sandovsky-Losica H
    Sabouraudia; 1981 Dec; 19(4):267-73. PubMed ID: 7034238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycobacterial polar glycopeptidolipids enhance resistance to experimental murine candidiasis.
    Lagrange PH; Fourgeaud M; Neway T; Pilet C
    C R Acad Sci III; 1995 Mar; 318(3):359-65. PubMed ID: 7788504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene.
    Doyle TC; Nawotka KA; Kawahara CB; Francis KP; Contag PR
    Microb Pathog; 2006 Feb; 40(2):82-90. PubMed ID: 16426810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans.
    Held K; Thiel S; Loos M; Petry F
    Mol Immunol; 2008 Sep; 45(15):3934-41. PubMed ID: 18672286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mucosal candidiasis].
    Veselská A; Svejda J; Richter J
    Cas Lek Cesk; 1991 Nov; 130(18-19):561-2. PubMed ID: 1764721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.